K313dup is a recurrent CEBPA mutation in de novo acute myeloid leukemia (AML)

By Carnicer Maria  

Annals of Hematology, Vol. 87, Iss. 10, 2008-10 ,pp. : 819-827

Springer Publishing Company

Access to resources Recommend Favorite

Meningioma 1 (MN1) expression: Refined risk stratification in acute myeloid leukemia with normal cytogenetics (CN-AML)

By Aref Salah   Ibrahim Lamiaa   Morkes Hana   Azmy Emad   Ebrahim Maha  

Hematology, Vol. 18, Iss. 5, 2013-09 ,pp. : 277-283

Maney Publishing

Access to resources Recommend Favorite

VEGF depletion enhances bcr-abl-specific sensitivity of arsenic trioxide in chronic myelogenous leukemia

By Luo Xiaochuang   Feng Maoxiao   Zhu Xuejiao   Li Yumin   Fei Jia   Zhang Yuan  

Hematology, Vol. 18, Iss. 6, 2013-11 ,pp. : 333-339

Maney Publishing

Access to resources Recommend Favorite

CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age

By Heuvel-Eibrink Marry   Holt Bronno   Burnett Alan   Knauf Wolfgang   Fey Martin   Verhoef Gregor   Vellenga Edo   Ossenkoppele Gert   Löwenberg Bob   Sonneveld Pieter  

Annals of Hematology, Vol. 86, Iss. 5, 2007-05 ,pp. : 329-337

Springer Publishing Company

Access to resources Recommend Favorite

WT1 mutation in pediatric patients with acute myeloid leukemia: a report from the Japanese Childhood AML Cooperative Study Group

By Sano Hirozumi   Shimada Akira   Tabuchi Ken   Taki Tomohiko   Murata Chisato   Park Myoung-ja   Ohki Kentaro   Sotomatsu Manabu   Adachi Souichi   Tawa Akio   Kobayashi Ryoji   Horibe Keizo   Tsuchida Masahiro   Hanada Ryoji   Tsukimoto Ichiro   Hayashi Yasuhide  

International Journal of Hematology, Vol. 98, Iss. 4, 2013-10 ,pp. : 437-445

Springer Publishing Company

Access to resources Recommend Favorite